Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 25, 2019 at 10:02: PM
via Mark Timney, the ex-Purdue Pharma CEO named in dozens of lawsuits against the OxyContin maker, stands to earn over $85 million in Novartis’s $9.7 billion buyout of the Medicines Company.

article source
 




Top Bottom
Back
Quote